CA A Cancer Journal for Clinicians · 2016 · 801 citations · 84 references
MedicineOncologyPreventive MedicineCancer EpidemiologyCancer PreventionEpidemiologyCancer DisparitiesCancer IncidenceCancer MortalityCancer RegistriesColorectal CancerMalignant NeoplasmsCancer Epidemiology By EthnicityCancer Epidemiology By RaceCancer Incidence Data CollectionCancer Incidence EpidemiologyColorectal Cancer MortalityDeath RatesRacial Disparities Over TimeSex Disparities In Cancer
In this article, the American Cancer Society provides the estimated number of new cancer cases and deaths for blacks in the United States and the most recent data on cancer incidence, mortality, survival, screening, and risk factors for cancer. Incidence data are from the National Cancer Institute, the Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries, and mortality data are from the National Center for Health Statistics. Approximately 189,910 new cases of cancer and 69,410 cancer deaths will occur among blacks in 2016. Although blacks continue to have higher cancer death rates than whites, the disparity has narrowed for all cancers combined in men and women and for lung and prostate cancers in men. In contrast, the racial gap in death rates has widened for breast cancer in women and remained level for colorectal cancer in men. The reduction in overall cancer death rates since the early 1990s translates to the avoidance of more than 300,000 deaths among blacks. In men, incidence rates from 2003 to 2012 decreased for all cancers combined (by 2.0% per year) as well as for the top 3 cancer sites (prostate, lung, and colorectal). In women, overall rates during the corresponding time period remained unchanged, reflecting increasing trends in breast cancer combined with decreasing trends in lung and colorectal cancer rates. Five-year relative survival is lower for blacks than whites for most cancers at each stage of diagnosis. The extent to which these disparities reflect unequal access to health care versus other factors remains an active area of research. Progress in reducing cancer death rates could be accelerated by ensuring equitable access to prevention, early detection, and high-quality treatment. CA Cancer J Clin 2016;66:290-308. © 2016 American Cancer Society.
84
SEER Cancer Statistics Review, 1975-2003
Lynn A. G. Ries, D. Harkins, Martin Krapcho et al. · ScholarWorks - Georgia State University (Georgia State University) · 2006 · 11.5K citations · Full text
Medicine, Biostatistics, Oncology +12
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Gerald L. Andriole, E. David Crawford, Robert L. Grubb et al. · New England Journal of Medicine · 2009 · 2.9K citations · Full text
Participation in Cancer Clinical Trials
Vivek H. Murthy, Harlan M. Krumholz, Cary P. Gross · JAMA · 2004 · 2.1K citations
International Variation in Prostate Cancer Incidence and Mortality Rates
Ahmedin Jemal, Joannie Lortet‐Tieulent, Elizabeth Ward et al. · European Urology · 2012 · 1.5K citations